Skip to main content
. 2022 Feb 4;14(2):362. doi: 10.3390/pharmaceutics14020362

Figure 4.

Figure 4

The generalized architecture to develop a theranostic agent with photoacoustic imaging properties, designed to visualize and treat malignant tumor cells. The different components of the “theranostic puzzle” can be combined in multiple, and different, ways to adduce the desired properties to the final fully assembled theranostic agent.